Skip to main content
SpringerLink
Log in

Adalimumab/etanercept/golimumab

Paradoxical psoriasis: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Apaydin H, et al. Secukinumab can treat psoriasis induced by anti-TNF-alpha therapy in patients with ankylosing spondylitis: Case series. International Journal of Rheumatic Diseases 23: 454-456, No. 3, Mar 2020. Available from: URL: http://doi.org/10.1111/1756-185X.13791

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab/etanercept/golimumab. Reactions Weekly 1797, 17 (2020). https://doi.org/10.1007/s40278-020-76524-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-76524-8

Search

Navigation